Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × Radiosurgery × Clear all

Phase

Phase NA 6 Phase 2 4 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 20 Carcinoma, Non-Small-Cell Lung 14 Pancreatic Neoplasms 11 Neoplasm Metastasis 10 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 7 Glioblastoma 7 Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Glioma 5 Carcinoma, Hepatocellular 5 Neoplasms 4 Head and Neck Neoplasms 4 Uveal Melanoma 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Oligodendroglioma 2 Mouth Neoplasms 2 Liver Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Gliosarcoma 2 Fallopian Tube Neoplasms 2

Interventions

Doxorubicin 23 Cyclophosphamide 23 Gemcitabine 14 Radiotherapy 11 Filgrastim 11 pazopanib 10 Cisplatin 9 pembrolizumab 8 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Carboplatin 6 Bevacizumab 6 selinexor 5 olaratumab 4 aflibercept 4 Topotecan 4 Thiotepa 4 Temozolomide 4 Nivolumab 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05821231 2025-07-31

MEDISARC-SBRT

Institut Claudius Regaud

Phase 1 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡